(Q37387812)

20 August 2017

0 references

1 reference

title

Intradermal hepatitis B vaccination: a systematic review and meta-analysis (English)

1 reference

20 August 2017

0 references

1 reference

1 reference

1

Laura Sangaré

1 reference

20 August 2017

Lisa Manhart

2

1 reference

20 August 2017

Darin Zehrung

series ordinal

3

1 reference

20 August 2017

Chia C Wang

series ordinal

4

1 reference

20 August 2017

language of work or name

English

0 references

publication date

4 February 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

27

1 reference

20 August 2017

issue

12

1 reference

20 August 2017

page(s)

1777-1786

1 reference

Hepatitis B virus infection: epidemiology and vaccination

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Vaccines for preventing hepatitis B in health-care workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

A randomized double-blind clinical trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine compared with a plasma-derived vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Clinical evaluation of low dose intradermally administered hepatitis B vaccine: a comparison of plasma-derived and recombinant yeast-derived vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Immunization of hospital personnel with low-dose intradermal hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Intradermal hepatitis B vaccination in health care workers. Response rate and experiences from vaccination in clinical practise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

INTRADERMAL VACCINATION AGAINST HEPATITIS B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Effectiveness of intradermal hepatitis B immunization of hospital staff

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Intradermal hepatitis B immunization with yeast-derived vaccine: serological response by sex and age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Comparison of intradermal and intramuscular hepatitis B vaccination in university students

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Comparison of the immunogenicity of hepatitis B vaccine administered intradermally and intramuscularly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Intramuscular versus intradermal administration of a recombinant hepatitis B vaccine: a comparison of response rates and analysis of factors influencing the antibody response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Intradermal, subcutaneous or intramuscular administration of hepatitis B vaccine: side effects and antibody response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Trials of intradermal hepatitis B vaccines in Gambian children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Comparative trial of low-dose, intradermal, recombinant- and plasma-derived hepatitis B vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Intradermal hepatitis B vaccination in a large hospital employee population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Low-dose intradermal versus intramuscular administration of recombinant hepatitis B vaccine: a comparison of immunogenicity in infants and preschool children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

High seroprotection rate induced by intradermal administration of a recombinant hepatitis B vaccine in young healthy adults: comparison with standard intramuscular vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Intradermal and intramuscular route for vaccination against hepatitis B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Intradermal hepatitis B vaccination in an abbreviated schedule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Low-dose (2 micrograms) hepatitis B vaccination in medical students: comparable immunogenicity for intramuscular and intradermal routes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Immunogenicity of low-dose intramuscular and intradermal vaccination with recombinant hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Intradermal vs intramuscular hepatitis B vaccinations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Low-dose intradermal and intramuscular vaccination against hepatitis B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Intradermal Hepatitis B Vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Comparison of higher-dose intradermal hepatitis B vaccination to standard intramuscular vaccination of healthcare workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Comparison of three different schedules of vaccination against hepatitis B in health care workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Serum antibody responses after intradermal vaccination against influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Immune functions of the skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Clinical trial of the intradermal administration of hepatitis B vaccine produced at the Department of Medical Research, Myanmar

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

A low-dose intradermal hepatitis B vaccine programme in health-care workers and students is highly effective and cost saving: a retrospective follow-up survey in the clinical setting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Intradermal immunization with novel plasmid DNA-coated nanoparticles via a needle-free injection device

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Intradermal vaccine delivery: will new delivery systems transform vaccine administration?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

Optimization of a jet-propelled particle injection system for the uniform transdermal delivery of drug/vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.043

10.1016/J.VACCINE.2009.01.043

7 January 2021

Identifiers

DOI

1 reference

20 August 2017

1 reference